Related Experiment Videos

Cryptococcal meningitis: clinical, diagnostic and therapeutic overviews

P Satishchandra1, T Mathew, G Gadre

  • 1Department of Neurology, National Institute of Mental Health and Neurosciences (NIMHANS) and St. Johns Medical College Hospital, Bangalore, India. psatish@nimhans.kar.nic.in

Neurology India
|October 9, 2007
PubMed

Insights

Cryptococcal meningitis is a significant threat in AIDS patients, but highly active antiretroviral therapy (HAART) is changing trends. Early diagnosis and antifungal treatment are crucial for recovery in both HIV-positive and other immunocompromised individuals.

Area of Science:

  • Infectious Diseases
  • Neuroscience
  • Immunology

Background:

  • Cryptococcal meningitis is a major cause of death in AIDS patients and a common opportunistic neuro-infection in HIV-seropositive individuals.
  • Highly active antiretroviral therapy (HAART) has improved patient outcomes, altering the epidemiology of cryptococcal meningitis.
  • This infection also affects non-HIV immunocompromised patients (e.g., those with diabetes, cancer, or organ transplants) and rarely healthy individuals.

Purpose of the Study:

  • To discuss the changing trends in cryptococcal meningitis, particularly in the context of widespread HAART use.
  • To highlight the importance of considering cryptococcal meningitis in the differential diagnosis of chronic meningitis.
  • To emphasize the challenges and rewards of treating cryptococcal infections.

Main Methods:

  • Review of current trends and epidemiological shifts in cryptococcal meningitis.
  • Discussion of diagnostic considerations for chronic meningitis.
  • Overview of treatment challenges and outcomes for cryptococcal infections.

Main Results:

  • HAART has led to significant improvements in the quality and length of life for HIV-infected individuals, impacting cryptococcal meningitis trends.
  • The availability of generic HAART in India has increased treatment access and decreased costs.
  • Diagnosis is achievable once considered, and treatment, though challenging, can lead to recovery.

Conclusions:

  • Cryptococcal meningitis remains a critical concern, especially in immunocompromised populations.
  • Effective management requires timely diagnosis and appropriate antifungal therapy.
  • Improved HAART access is reshaping the landscape of HIV-related opportunistic infections.

Related Concept Videos

Cryptococcal Meningitis01:27

Cryptococcal Meningitis

Cryptococcal meningitis is a life-threatening opportunistic infection predominantly associated with HIV/AIDS, accounting for over 100,000 deaths annually worldwide. However, it also affects individuals with other forms of immunosuppression, including those undergoing immunosuppressive therapy, organ transplant recipients, patients with innate immunodeficiencies, and individuals with hematological disorders. The infection is caused mainly by Cryptococcus neoformans and Cryptococcus gattii,...
Viral Meningitis01:18

Viral Meningitis

Viral meningitis is the most common form of meningitis and is often referred to as aseptic meningitis to indicate the absence of bacterial involvement. It is generally milder than bacterial meningitis, with symptoms including fever, headache, stiff neck, drowsiness, nausea, photophobia, and vomiting. Rarely, more severe manifestations or death may occur. Common causative agents include enteroviruses, particularly coxsackie A and B viruses and echoviruses, all members of the Enterovirus genus...
Bacterial Meningitis I: Introduction01:22

Bacterial Meningitis I: Introduction

Bacterial meningitis is a severe, life-threatening inflammation of the meninges, particularly the pia mater and arachnoid mater, affecting the subarachnoid space, ventricles, and cerebrospinal fluid (CSF). If untreated, it can lead to significant neurological complications or death.Causative AgentsCommon pathogens vary with age and immune status. In adults, major organisms include Streptococcus pneumoniae, Neisseria meningitidis, and Haemophilus influenzae. Streptococcus agalactiae (group B...
Bacterial Meningitis II: Pathophysiology01:26

Bacterial Meningitis II: Pathophysiology

Bacterial meningitis typically begins when pathogens such as Neisseria meningitidis and Streptococcus pneumoniae colonize the nasopharynx and invade the bloodstream. This process is facilitated by bacterial virulence factors, such as polysaccharide capsules, which resist phagocytosis and complement-mediated killing. Less commonly, bacteria reach the central nervous system via contiguous spread from infections like otitis media or sinusitis, through congenital or acquired dural defects, or...
Brain Abscess l: Introduction01:26

Brain Abscess l: Introduction

A brain abscess is a focal, intracerebral infection characterized by a localized collection of pus within the brain parenchyma, resulting from microbial invasion and the body’s inflammatory response. It progresses through stages: early and late cerebritis, followed by early and late capsule formation, reflecting tissue destruction, immune response, and eventual encapsulation.Etiology and PathogenesisCausative organisms vary with source and host factors, often involving polymicrobial infections,...
Acute Pyelonephritis II: Diagnostic Studies and Management01:28

Acute Pyelonephritis II: Diagnostic Studies and Management

Introduction:For diagnosing acute pyelonephritis, a comprehensive patient history is collected to identify symptoms such as dysuria, frequent or urgent urination, flank pain, or costovertebral angle (CVA) tenderness that may suggest a kidney infection.Physical ExaminationDuring the physical examination, CVA tenderness is assessed. This involves gentle percussion over the costovertebral angle, where tenderness often indicates a kidney infection.Diagnostic TestsUrinalysis: Used to identify white...